Latest Articles

Publication Date
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - sharewise.com

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia sharewise.com

Published: Dec. 3, 2025, 5:04 a.m.
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything - Times of India

Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything Times of India

Published: Dec. 3, 2025, 12:36 a.m.
Women's risk of hypertension and cardiovascular disease subtypes by number of cycles of assisted reproductive technologies: a Norwegian registry-linkage study.

To assess the risk of hypertension and cardiovascular disease (CVD) in relation to the number of assisted reproductive technologies (ART) cycles.

Published: Dec. 3, 2025, midnight
Sexual Functioning and Quality of Life Among Women With Endometriosis: A French Cross-Sectional Survey.

Evidence suggests that symptoms of endometriosis related to sexual dysfunction can disrupt intimate and sexual partnerships. The goal of this study was to understand the association between quality of life …

Published: Dec. 3, 2025, midnight
AI-Driven Advances in Women's Health Diagnostics: Current Applications and Future Directions.

Background: Women's health has historically served as an incubator for major medical innovations yet often faces relative neglect in sustained funding and implementation. The rise of artificial intelligence (AI) and …

Published: Dec. 3, 2025, midnight
Best Walmart Cyber Monday 2025 deals: Legos, Dyson vacuums, AirPods discounts - Mashable

Best Walmart Cyber Monday 2025 deals: Legos, Dyson vacuums, AirPods discounts Mashable

Published: Dec. 2, 2025, 9:20 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire

Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan

Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan

Published: Dec. 2, 2025, 1:05 p.m.
Singapore start-up raises US$1.5m to redefine menstrual health - FemTech World

Singapore start-up raises US$1.5m to redefine menstrual health FemTech World

Published: Dec. 2, 2025, 12:49 p.m.
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia - MarketScreener

Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia MarketScreener

Published: Dec. 2, 2025, 7:36 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!